
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $159M | -- | -- | $0.28 | -- |
08/06/2025 | Q2 | $151.3M | -- | -- | $0.23 | -- |
05/07/2025 | Q1 | $166M | $167.3M | $0.20 | $0.32 | -$0.12 |
02/12/2025 | Q4 | $176.3M | $182.1M | $0.26 | $0.40 | -$0.14 |
11/06/2024 | Q3 | $180.6M | $184.8M | $0.36 | $0.45 | -$0.09 |
08/06/2024 | Q2 | $176M | $175.9M | $0.25 | $0.43 | -$0.18 |
05/07/2024 | Q1 | $170.6M | $174.5M | $0.37 | $0.41 | -$0.04 |
02/14/2024 | Q4 | $169.1M | $173.9M | $0.37 | $0.42 | -$0.05 |
11/06/2023 | Q3 | -- | -- | $0.42 | $0.37 | $0.05 |
08/07/2023 | Q2 | -- | -- | -$1.61 | $0.30 | -$1.91 |
05/08/2023 | Q1 | -- | -- | $0.17 | $0.20 | -$0.03 |
02/15/2023 | Q4 | -- | -- | $2.00 | $0.32 | $1.68 |
11/07/2022 | Q3 | -- | -- | $0.27 | $0.41 | -$0.14 |
08/08/2022 | Q2 | -- | -- | $0.18 | $0.29 | -$0.11 |
05/09/2022 | Q1 | -- | -- | $0.24 | $0.35 | -$0.11 |
02/16/2022 | Q4 | -- | -- | $0.15 | $0.37 | -$0.22 |
11/02/2021 | Q3 | -- | -- | $0.17 | $0.35 | -$0.18 |
08/03/2021 | Q2 | -- | -- | $0.12 | $0.27 | -$0.15 |
05/04/2021 | Q1 | -- | -- | $0.05 | $0.23 | -$0.18 |
02/11/2021 | Q4 | -- | -- | -$0.00 | $0.32 | -$0.32 |
10/27/2020 | Q3 | -- | -- | $0.01 | $0.20 | -$0.19 |
08/03/2020 | Q2 | -- | -- | -$0.17 | $0.07 | -$0.24 |
05/07/2020 | Q1 | -- | -- | -$0.01 | $0.06 | -$0.07 |
02/13/2020 | Q4 | -- | -- | -$0.69 | $0.08 | -$0.77 |
11/04/2019 | Q3 | -- | -- | -$0.25 | $0.00 | -$0.25 |
08/05/2019 | Q2 | -- | -- | -$0.33 | -$0.09 | -$0.24 |
05/06/2019 | Q1 | -- | -- | -$0.40 | -$0.21 | -$0.19 |
02/11/2019 | Q4 | -- | -- | -$3.11 | -$0.16 | -$2.95 |
11/01/2018 | Q3 | -- | -- | -$0.19 | $0.08 | -$0.27 |
08/02/2018 | Q2 | -- | -- | -$5.02 | -- | -- |
05/07/2018 | Q1 | -- | -- | -$0.34 | -- | -- |
02/12/2018 | Q4 | -- | -- | -$0.12 | -- | -- |
11/02/2017 | Q3 | -- | -- | -$0.51 | -- | -- |
08/03/2017 | Q2 | -- | -- | -$0.49 | -- | -- |
05/04/2017 | Q1 | -- | -- | $0.04 | -- | -- |
01/16/2017 | Q4 | -- | -- | -$0.13 | -- | -- |
11/01/2016 | Q3 | -- | -- | -$1.78 | -- | -- |
08/01/2016 | Q2 | -- | -- | -$0.82 | -- | -- |
05/04/2016 | Q1 | -- | -- | -$0.40 | -- | -- |
02/22/2016 | Q4 | -- | -- | -$0.25 | -- | -- |
10/28/2015 | Q3 | -- | -- | $0.13 | -- | -- |
Veeco Instruments reported $167.3M worth of top line sales in its most recent quarter.
Veeco Instruments announced earnings per share of $0.20 which represents a miss of analyst forecast a $0.32 per share.
Veeco Instruments reported $68.5M that represents $1.14 per share over the last quarter.
Veeco Instruments's earnings are forecast to decrease from $1.23 per share to $1.72 per share next year representing a decrease of -2.42%.
Veeco Instruments's next earnings date is August 6, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.